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Force and motion generated by skeletal muscle ultimately depends on the cyclical
interaction of actin with myosin. This mechanical process is regulated by intracellular Ca2+
through the thin filament-associated regulatory proteins i.e.; troponins and tropomyosin.
Muscular dystrophies are a group of heterogeneous genetic affections characterized by
progressive degeneration and weakness of the skeletal muscle as a consequence of
loss of muscle tissue which directly reduces the number of potential myosin cross-
bridges involved in force production. Mutations in genes responsible for skeletal muscle
dystrophies (MDs) have been shown to modify the function of contractile proteins and
cross-bridge interactions. Altered gene expression or RNA splicing or post-translational
modifications of contractile proteins such as those related to oxidative stress, may affect
cross-bridge function by modifying key proteins of the excitation-contraction coupling.
Micro-architectural change in myofilament is another mechanism of altered cross-bridge
performance. In this review, we provide an overview about changes in cross-bridge
performance in skeletal MDs and discuss their ultimate impacts on striated muscle
function.
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INTRODUCTION
Muscular dystrophies (MDs) are a group of more than 30 clin-
ical and molecular heterogeneous genetic disorders that cause
progressive degeneration of the skeletal muscle fibers. They are
characterized by severe muscle weakness that generally affects
limb, axial, and/or facial muscles to a variable extent. The age of
onset, severity and rate of progression greatly vary in the differ-
ent forms of MD. The primary cause of various forms of MDs is
an individual mutation in genes encoding a wide variety of pro-
teins, including extracellular matrix (ECM) proteins, transmem-
brane, and membrane-associated proteins, cytoplasmic proteases
and nuclear proteins. Detailed classification and list of causative
genes in MD have been recently reviewed (Cohn and Campbell,
2000; Flanigan, 2012; Kaplan and Hamroun, 2012; Mercuri and
Muntoni, 2013). Although still incompletely understood, consid-
erable progress has been now made to reveal the pathophysiolog-
ical mechanisms in MDs. It has been shown that most MDs share
Abbreviations: ADP, adenosine 5′-diphosphate; ATP, adenosine 5′-triphosphate;
CB, cross-bridge; DMD, Duchenne muscular dystrophy; ECM, extracellular
matrix; FSHD, fascioscapulohumeral muscular dystrophy; MD, muscular dystro-
phy; MsrA and MrB, methionine sulfoxyde reductase A and B; MyHC, myosin
heavy chain; nNOS, neuronal NO synthase; NO, nitric oxide; Pi, inorganic phos-
phate; ROS, reactive oxygen species; Tm, tropomyosin.
common pathologic features, such as altered Ca2+ homeosta-
sis, infiltration of muscle tissue by inflammatory immune cells,
accretion of proinflammatory and profibrotic cytokines, activa-
tion of proteolytic enzymes, metabolic/mitochondrial alterations,
intracellular accumulation of reactive oxygen species (ROS) pro-
duction, and/or defective autophagy, which can contribute to
muscle wasting. At the earliest stages of the disease, reduced
myofibrillar protein content can occur in apparent uninjured
fibers, secondary to an imbalance between protein synthesis and
proteolysis (McKeran et al., 1977; Warnes et al., 1981). Then,
successive rounds of degeneration and regeneration lead to fibro-
sis and fatty replacement of muscle tissue and in turn reduce
the number of potential cross-bridges (CBs) generating force
(Figure 1). In addition, functional changes in the CB properties
may contribute to muscle weakness in distinct types of mus-
cle disease. It is well-established that shift in the relative myosin
isoform expression is associated with modifications of the kinet-
ics of actomyosin interactions (Bar and Pette, 1988; Schiaffino
et al., 1989; Schiaffino and Reggiani, 1996). However, there are
also increasing evidences that CB properties can change with
no change in myosin isoform content (Coirault et al., 2002;
Canepari et al., 2009), suggesting that post-translational modi-
fications of contractile proteins have significant role in muscle
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FIGURE 1 | Schematic representation of the main mechanisms leading
to muscle weakness in MDs. Altered CB cycle in muscular dystrophy can
arise from multiples causes including progressive loss of muscle tissue due
to necrosis, fibrosis, atrophy, or oxidative damage, micro-architectural
alterations in myofilaments, altered redox regulation or pathological changes
in contractile protein isoforms. These abnormalities in turn directly reduce the
number, the force, the kinetics of active CBs or the transmission of force
produced by the CBs.
weakness (Figure 1). The present review focuses on the changes in
the function of contractile proteins and in CB performance that
may occur in the context of skeletal muscle dystrophies (MDs)
and their contribution to the pathophysiological mechanisms of
these diseases.
CYCLICAL INTERACTIONS OF ACTIN WITH MYOSIN
Contractile force of striated muscle is produced within the
half-sarcomere—the functional contractile unit—by the cyclical
interactions of actin filament with myosin molecule, the mus-
cle molecular motor. These cyclical interactions are controlled by
membrane-located mechanisms that trigger intracellular raise of
Ca2+and mechanisms inside the sarcomere itself. In skeletal mus-
cle, sarcomeric mechanisms mainly involve the Ca2+-controlled
conformational change of the regulatory proteins troponins and
tropomyosin (Tm), the functional properties of myosin, and
strong cooperative interaction between neighboring troponin-Tm
unit along the actin filament (Gordon et al., 2000).
In resting muscle, intracellular Ca2+ concentration ([Ca2+]i)
is low and the C-terminal domain of troponin I immobilizes
the Tm in a position that prevents the binding of myosin to
actin (Galinska-Rakoczy et al., 2008). Upon membrane depo-
larization, Ca2+ is released from the sarcoplasmic reticulum
and binds to troponin C, initiating azimuthal movement of Tm
around the actin-containing thin filament. This in turn exposes
the sites on actin on which the myosin heads can attach (Kress
et al., 1986; Geeves et al., 2005). In the conventional view,
myosin binding is solely determined by the Ca2+ transient caus-
ing structural changes in the thin filament. However, numerous
studies have reported Ca2+-induced structural change in the
myosin-containing thick filaments before myosin binding to the
thin filament (Huxley et al., 1982; Lowy and Poulsen, 1990; Yagi,
2003; Reconditi et al., 2011). This has led to the proposal of
a modified model of muscle activation in which fast coordi-
nated changes in the structures of both thick and thin filaments
follow concomitantly upon the rise in intracellular free Ca2+
concentration (Reconditi et al., 2014).
Myosin head binding to actin occurs first in a low binding,
pre-force-generating state (Figure 2, step a). At this state, the
CB has already hydrolyzed the adenosine 5′-triphosphate (ATP),
but the products adenosine 5′-diphosphate (ADP) and inorganic
phosphate (Pi) are still bound to the myosin head (Lymn and
Taylor, 1971; Pate and Cooke, 1989). Then, the CB goes through
the power stroke (Figure 2, step b), during which the myosin
head can generate a force of several piconewtons or an axial
displacement of the actin filament toward the center of the sar-
comere of 5–10 nm in vitro (Molloy et al., 1995; Veigel et al.,
1998; Mehta et al., 1999; Reconditi et al., 2011) or 8–13 nm in situ
(Reconditi et al., 2004). There are evidences that force genera-
tion precedes the Pi release (Dantzig et al., 1992; Caremani et al.,
2008). Subsequent steps involve the release of ADP (Figure 2, step
c), and the binding of ATP that rapidly dissociates the actomyosin
complex (Figure 2, step d). When unbound from actin, myosin
hydrolyzes ATP and reverses the power stroke, thus returning to
its original position and allowing a new cycle to start (Eisenberg
and Greene, 1980; Steffen and Sleep, 2004) (Figure 2, step e).
Thus, at the molecular level, skeletal myosin is a molecular motor
that transduces chemical energy produced by the hydrolysis of
one ATP molecule into mechanical work (Huxley, 1957; Huxley
and Simmons, 1971; Lymn and Taylor, 1971; Eisenberg et al.,
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FIGURE 2 | The CB cycle. Step a: attachment of myosin to actin. This step
begins with the “weak binding” of actin (in magenta) to the myosin head
(in brown). A stereospecific interaction between actin and myosin leads to
strong binding of actin to myosin. Step b: power stroke. The loss of
inorganic phosphate (Pi) is assumed to trigger the onset of the power
stroke and a reversal of the previous conformational bent. Step c: ADP
release step. The power stroke induces reopening of the nucleotide binding
pocket and ADP release. Step d: ATP binding. ATP can then rapidly bind to
myosin which dissociates from actin. Step e: ATP hydrolysis. ATP is then
rapidly hydrolyzed to ADP and Pi.
1980; Pate and Cooke, 1989; Gordon et al., 2000). Skeletal MDs
may reduce the number of active CBs producing force but may
also potentially affect various steps of the cyclical interactions of
actin with myosin, thus reducing the unitary force produced by
each CB and/or modifying the CB kinetics.
CHANGES IN CB KINETICS RELATED TO MD-INDUCED SHIFT
IN MYOSIN ISOFORM
The events in the CB cycle are essentially the same for all mus-
cle myosins, but the kinetics of acto-myosin interaction varies
widely among myosin heavy chain (MyHC) isoforms. Although
the physiological differences between fast and slow skeletal muscle
fibers depend on more than just differences in MyHC isoforms, it
is well established that MyHC isoforms are a major determinant
of the large variability in contractile and energetic properties of
muscle fibers (Pette and Staron, 1990; Bottinelli et al., 1994a,b).
The existence of several MyHC isoforms differentially distributed
in various fibers makes MyHCs useful to study fiber heterogeneity
and plasticity inmammalianmuscles. In the adult skeletal muscle,
four MyHC isoforms can be expressed, namely the slowMyHC -1
and the fast MyHC -2A,MyHC-2X, andMyHC-2B, coded respec-
tively by the Myh7, Myh2, Myh1, and Myh4 genes (Bar and Pette,
1988; Schiaffino et al., 1989; Schiaffino and Reggiani, 1996).
Changes in the proportion of fast relative to slow fiber types
are frequently observed in muscular dystrophy, and may result
either from a reduced muscular activity in affected patients or
from a physiopathological consequence of the gene mutation.
The pattern of wasted muscle and affected fibers is highly
variable among the types of MDs. Preferential involvement in
fast type 2 muscle fibers is a common feature in Duchenne
Muscular Dystrophy (DMD) (Webster et al., 1988), with early
disappearance of muscle fibers expressing MyHC-2X transcripts
(Pedemonte et al., 1999). Likewise, slow type 1 muscle fiber
predominance has been reported in patients with facioscapu-
lohumeral muscular dystrophy (FSHD) (Celegato et al., 2006),
dysferlinopathy (Fanin and Angelini, 2002) and congenital mus-
cular dystrophy type Ullrich (Schessl et al., 2008), suggesting a
selective loss of fast-twitch/type 2 muscle fibers (D’Antona et al.,
2007) or an active fiber typing conversion process (Schessl et al.,
2008; De La Torre et al., 2009). This preferential involvement of
the fastest fiber type leads to a fast to slow shift among fast MyHC
isoforms in the dystrophic muscles (Stedman et al., 1991; Petrof
et al., 1993; Coirault et al., 1999), which may represent an adap-
tive response that would tend to preserve the economy of force
contraction. However, fiber-type composition has been shown
to be differently affected in other MDs. Hypertrophy of type
2 fibers without type 1 fiber atrophy have been found in biop-
sies of patients with laminopathies (Kajino et al., 2014), whereas
MyHC-2a fibers are markedly atrophied in affected cricopha-
ryngeal muscle of oculopharyngeal muscular dystrophy patients
(Gidaro et al., 2013). How mutations responsible for MDs dif-
ferently affect myofiber-type specification and/or MyHC deserve
further studies. In addition to adult myosin isoform remod-
eling, dystrophic fiber can express developmental embryonic
and neonatal MyHCs, coded by Myh3 and Myh8, respectively
(Wieczorek et al., 1985; Sartore et al., 1987). Such developmental
or neonatal MyHC-expressing fibers can either be regenerat-
ing fibers or fibers that expressed inappropriate and immature
MyHC, as has been observed in some congenital myopathies
(Sewry, 1998).
Importantly, the different MyHC isoforms display large func-
tional differences regarding the actin-activated ATPase activity of
myosin, the rate of ADP release from acto-myosin during the time
of attachment, and the velocity with which they can move actin.
This results in large variability in contractile, thermodynamic,
and kinetic coupling according to the fiber type (Barany, 1967).
For instance, fibers containing MyHC-1 have nearly threefold
slower ATPase and lower tension cost than fibers with MyHC-
2X, while fibers with MyHC-2A are intermediate (Stienen et al.,
1996). Therefore, an increased proportion of the slow MyHC
isoforms would tend to improve muscle efficiency and may rep-
resent an adaptive response at least in some MDs. An opposite
response, namely a slow-to-fast shift with preferential atrophy of
slow fiber, accelerates the time cycle, reduces muscle efficiency
(Coirault et al., 1999) and thus may contribute to the exercise
intolerance in DMD patients. MyHC shift may also impact on CB
recruitment, given that attachment of fast myosin involves a CB-
mediated facilitation mechanism absent in slow MyHC isoforms
(Galler et al., 2009). Indeed, fast myosin heads already attached to
actin substantially accelerate the further attachment of neighbor-
ing myosin heads, thereby enabling a rapid change in the rate of
force development at high levels of activation (Galler et al., 2009).
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In contrast, slow MyHC isoforms have moderate dependence
on level of activation, enabling slow CB recruitment to become
faster only gradually at higher levels of activation (Galler et al.,
2009). Thus, pathologic changes in myosin isoforms modify spe-
cific steps of the CB cycling as well as the overall kinetics of the CB
cycle, with functional consequences on muscle performance and
energy cost of contraction.
CB ALTERATIONS CAUSED BY MICRO-ARCHITECTURAL
CHANGES IN MYOFILAMENTS
Striated muscles are characterized by a highly ordered struc-
ture that is critical for normal function and muscle homeostasis.
Micro-architectural changes in myofilaments are likely contribu-
tors to muscle weakness in MDs, either directly by affecting the
function of critical structural proteins, or indirectly, by increasing
the activity of Ca2+-dependent proteases.
In striated muscle, the dystrophin glycoprotein complex is
preferentially located at the costamere (Ervasti and Campbell,
1991), a protein network connecting the outermost myofibrils
to the sarcolemma at each Z-disc (Pardo et al., 1983; Ervasti
and Campbell, 1991; Bloch and Gonzalez-Serratos, 2003; Ervasti,
2003; Michele and Campbell, 2003). These lateral linkages are
critical in the maintenance of sarcomere stability and in the trans-
mission of forces generated by the CBs (Figure 3) (Rybakova
et al., 2000; Bloch and Gonzalez-Serratos, 2003; Ervasti, 2003).
Indeed, while part of the forces generated in sarcomeres is lon-
gitudinally transmitted down myofibrils in muscle to the ten-
don, costameres are critical to transmit the forces laterally to
the ECM and neighboring muscle fibers (Street, 1983; Ervasti,
2003; Bloch et al., 2004; Ramaswamy et al., 2011). Dystrophin
deficiency reduces the lateral transfer of forces between acti-
vated fibers (Ramaswamy et al., 2011), thus compromising the
homogeneity of sarcomere contraction between adjacent fibers
and impairing the efficacy of force transmission. As a result, each
fiber tends to act as an independent longitudinal force gener-
ator, thus increasing the susceptibility of muscle membrane to
contraction-induced muscle damage.
Skeletal muscle fiber contains the ubiquitously expressed and
well-conserved family of Ca2+-dependent cysteine proteases cal-
pains, μ-calpain, and m-calpain, as well as a muscle-specific cal-
pain i.e., calpain-3 (Goll et al., 2003; Bartoli and Richard, 2005).
Elevated calpain amount, primarily due to a significant increase in
m-calpain concentration is observed in dystrophic muscles from
the mdx mice (Spencer et al., 1995), a mouse model of DMD.
Increased activity of calpains has been implicated in the pro-
gression of muscle wasting in dystrophic muscles (Spencer et al.,
1995; Alderton and Steinhardt, 2000; Tidball and Spencer, 2000;
Zhang et al., 2008). The two ubiquitous μ- and m-calpains both
cleave the same substrates in vitro, including the troponin com-
plex (Troponin C, Troponin I, and Troponin T), Tm, α-actinin,
titin, desmin, the Z-disk protein fodrin and the sarcolemmal
associated spectrin complex of proteins (Goll et al., 2003). Such
substrates are consistent with a role of μ- and m-calpains in sar-
comeric organization and/or dismantling. Interestingly, the two
sarcomeric tropomodulin isoforms Tmod1 and Tmod4 have been
recently identified as proteolytic targets of m-calpain in dys-
trophic muscle (Gokhin et al., 2014). Tropomodulins are dynamic
actin filament pointed-end-capping proteins (Weber et al., 1994),
that localize in sarcomere to each side of the M-line (Fowler et al.,
1993). Absence of Tmod1 and its replacement by Tmod3 and
Tmod4 in turn impair initial Tm movement over actin subunits
during thin filament activation, thus reducing both the fraction
of actomyosin CBs in the strongly bound state and fiber force-
generating capacity (Ochala et al., 2014). Calpain-3 binds to the
N2A region of titin (Sorimachi et al., 1995), but has also been
identified in the nucleus of muscle cells (Baghdiguian et al., 1999).
FIGURE 3 | Transmission of the forces generated in sarcomere. The
dystrophin-glycoprotein complex is preferentially located at the costamere,
a protein network that reside at the sarcolemma membrane in register
with the Z-lines of sarcomeres and that is critical in the lateral
transmission of forces generated by the CB to the ECM and neighboring
muscle fibers. Dystrophin deficiency at the lateral membrane alters
costamere assembly and thus may impair the efficacy of lateral force
transmission.
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Interestingly, it has been shown that calpain-3 binding to the
myofibrillar structure in vitro is modulated by the presence of
CBs locked in rigor (Murphy et al., 2006; Murphy and Lamb,
2009), thus supporting the hypothesis that CB interactions mod-
ulate calpain-3 activity. This may explain why in vivo, eccentric
exercise is the only physiological circumstance shown to result
in the activation of calpain-3 (Murphy et al., 2007). A number
of myofibrillar proteins have been identified as potential calpain-
3 substrates in vitro, but none have been confirmed as in vivo
targets. These include titin (at the PEVK region, adjacent to the
N2A region of titin), and myosin light chain (Cohen et al., 2006).
Future works are needed to determine the interrelation between
calpain-3 and the CB interactions.
MODULATIONS AND DAMAGE OF CB KINETICS BY
OXIDATIVE STRESS
DEFINITION AND INTRACELLULAR SOURCES OF OXIDATIVE STRESS IN
MDs
Oxidative stress has been reported as primum movens in both
loss of cell viability and contractile dysfunction in MDs (Ragusa
et al., 1997; Rando et al., 1998; Tidball and Wehling-Henricks,
2007; Menazza et al., 2010; Lawler, 2011). By definition, oxidative
stress refers to a deregulation of the cellular redox-status due to
an imbalance between reactive oxygen species (ROS) production
and antioxidant capacities.
There are numerous potential intracellular sources of ROS
in muscle tissue including the mitochondria (Murphy, 2009;
Brand, 2010), the family of nicotinamide adenine dinucleotide
phosphatate oxidases, now collectively known as NOX enzymes
family, and a wide range of enzymes, such as xanthine oxi-
dase, nitric oxide synthase, cyclo oxygenases, cytochrome P450
enzymes and lipoxygenases (Cheng et al., 2001). In addition,
extracellular sources of ROS can arise from other non-muscle cell
types, including activated neutrophils and macrophages (Moylan
and Reid, 2007).
Because striated muscle cells have to adapt very rapidly and
in a co-ordinated manner to changes in energy supply and oxy-
gen flux, the control of ROS production and redox-status is
tightly regulated during contraction. Importantly, the neuronal
form of nitric oxide synthase (nNOS) is normally present in the
sarcolemma of fast-twitch muscle fibers and associates with dys-
trophin (Brenman et al., 1995). Although the reaction between
nitric oxide (NO) and the superoxide anion is known to form
peroxynitrite, NO can also act as a protective molecule against
the damaging actions of ROS (Wink et al., 1995). Accordingly,
the absence of nNOS and NO in DMD muscle removes this pro-
tective action, increasing the susceptibility of DMDmuscle to the
damaging action of ROS (Brenman et al., 1995; Haycock et al.,
1996; Disatnik et al., 1998).
PHYSIOLOGICAL STRESS INDUCES REVERSIBLE MODIFICATIONS OF
PROTEINS THAT CONTRIBUTE TO NORMAL MUSCLE PHYSIOLOGY
There is increasing evidence that ROS reversibly modulate
important intracellular pathways involved in muscle homeosta-
sis (Droge, 2002; Smith and Reid, 2006; Jackson, 2008; Musaro
et al., 2010). Small, compartmentalized, and transient increases
in ROS regulate intracellular signals by reversible oxidation of
specific protein residues (Meng et al., 2002; Ghezzi, 2005; Janssen-
Heininger et al., 2008; Drazic et al., 2013). Hydrogen peroxide
modifies protein function by oxidizing the thiol (-SH) groups
of redox sensitive cysteine residues to form disulfide bonds
with adjacent cysteine residues, glutathione (glutathionylation),
or small protein thiols such as thioredoxin. Reduction of the
disulfide bond can then be obtained through the action of
enzymes such as glutaredoxin or the peroxiredoxins (Rhee, 2006;
Hashemy et al., 2007). Accordingly, specific cysteine and methio-
nine residues can function as redox-dependent switches, thereby
modulating the function of myofibrillar proteins (Nogueira et al.,
2009; Mollica et al., 2012; Gross and Lehman, 2013), phosphatase
or transcriptional activities (Xanthoudakis et al., 1992; Ji et al.,
2004; Powers et al., 2005, 2011; Jackson, 2008; Ugarte et al.,
2010). Indeed, recent findings indicate that myosin, actin, tro-
ponin I and Tm from skeletal muscle have cysteines that are
critical to the effects from oxidants (Nogueira et al., 2009; Mollica
et al., 2012; Gross and Lehman, 2013), and that accessibility
depends on the conformation of the CB (Gross and Lehman,
2013). In addition, the function of myosin (Nogueira et al., 2009)
and of the ryanodine 1 receptor (Bellinger et al., 2009) can be
reversibly modified by S-nitrosylation, a redox-related modifica-
tion of cysteine thiol by NO. Reversible oxidation of contractile
proteins likely regulates muscle force production and actomyosin
interactions, thereby contributing to the physiological adapta-
tion of muscle to mechanical challenge (Powers and Jackson,
2008). Disturbance or removal of this redox sensitivemodulations
may limit the adaptability of the CB kinetics, with deleterious
effects on muscle function and homeostasis (Stone and Yang,
2006; Linnane et al., 2007). Apart cysteine, methionine residue
can be oxidized to its sulfoxyde, generating a mixture of two
diastereoimers, denoted S and R. The S and the R forms are
reduced back to methionine by methionine sulfoxyde reductase
A (MsrA) and B (MsrB), respectively (Stadtman et al., 2002;
Petropoulos and Friguet, 2005; Ugarte et al., 2010). Interestingly,
recent studies have highlighted a new role for these Msr enzymes,
identifying them as actors controlling the assembly/disassembly
of actin filaments (Hung et al., 2013; Lee et al., 2013). A specific
oxidation-reduction (redox) enzyme, the Mical protein, selec-
tively modifies two methionines on the conserved pointed-end in
actin filaments. Oxidized methionines at these positions simul-
taneously disassemble and decrease the polymerization of actin
filaments (Hung et al., 2013). Recently, Hung et al. and Lee
et al. showed in Drosophila bristle processes model and in mouse
macrophages that MsrB1 stereospecifically reverses the oxidative
modification of the methionines introduced by Mical, indicating
that Msr system antagonizes the Mical-actin depolymerization
dependent process and reversibly control actin polymerization
(Hung et al., 2013; Lee et al., 2013). These data indicate new
post-translational regulatory mechanisms involving oxidoreduc-
tase systems, but also open up new paths of investigation in the
field of muscle diseases.
IRREVERSIBLE MODIFICATIONS OF PROTEINS: OXIDIZED PROTEINS
ARE DYSFUNCTIONAL AND ARE TARGETED TO REMOVAL
In contrast to reversible modifications caused by low oxidative
stress, chronic disruption of the oxidative balance and/or high
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levels of free ROS radicals cause potential biological damage,
termed oxidative stress. This is a complex process that probably
depends on the type of oxidant, on the site and intensity of its pro-
duction, on the composition and activity of various antioxidants
and on the ability of skeletal muscle to repair damaged fibers.
Irreversible damage of myofibrillar proteins may affect the CB
cycle, as observed after nitrosylation and carbonylation of myosin
(Coirault et al., 2007; Guellich et al., 2007), and target them
for catabolic proteolysis (Jung et al., 2007). Alternatively, oxida-
tive stress can activate caspases that in turn cleave myofibrillar
proteins and impair CB properties (Du et al., 2004).
FUNCTIONAL CONSEQUENCES OF ALTERED CB CYCLING ON
MUSCLE CONTRACTION
The functional consequences of altered CB cycle in MD remain
to be precisely determined. It has been reported that the reduced
muscle strength per cross section in mdx diaphragm is associated
with an accelerated cycle compared with control diaphragmmus-
cle (Coirault et al., 1999). Assuming that one molecule of ATP
is hydrolyzed per CB cycle (Huxley, 1957; Huxley and Simmons,
1971; Eisenberg et al., 1980), these data suggested that the over-
all cycle of ATP splitting takes place more rapidly in mdx than in
control mouse diaphragm, thus reducing the efficiency of mus-
cle contraction to sustain force. Overall, these data suggested that
absence of the sarcolemmal dystrophin protein leads to dam-
aged or dysfunctional myosin molecules that impair CB kinetics
and may account for the contractile deficit in mdx diaphragm.
However, while mechanical differences are observed betweenmdx
and control diaphragms at the intact muscle strip level, these dif-
ferences are not observed at the single permeabilized cell (Bates
et al., 2013). In addition, it was reported that myosin extracted
from bulk mdx mouse diaphragm muscle moves actin filaments
in an “in vitro motility assay” at a lower velocity than myosin
extracted from controls (Coirault et al., 2002). Consistent reduc-
tion in actin sliding velocity has been found in pure MyHC-2
isoform from mdx gastrocnemius muscle, but not in type 1
myosin from wild-type and mdx muscle (Canepari et al., 2009).
Therefore, observed changes in myosin velocity have been related
to a change in the intrinsic properties of themolecule, but was not
attributed to a change in the proportion of different myosin iso-
forms in the sample. In addition, it has been shown that nebulin
in skeletal muscle increases thin filament activation via increasing
CB cycling kinetics leading to an increased force and efficiency of
contraction (Chandra et al., 2009). Results from that study pro-
vide novel insights regarding nebulin-based nemaline myopathy.
Thus, complex mechanisms other than translational changes in
myosin isoform may contribute to CB modifications in muscu-
lar disorders. Future studies are needed to precisely determine
the contribution of post-translational modifications of contractile
proteins to muscle weakness in MDs.
CONCLUSIONS AND FUTURE DIRECTIONS
The mechanisms of muscle weakness have been a fundamental
question of the physiopathology of muscle dystrophy for more
than 50 years. It is now clear that the molecular causes responsible
for the impaired performance in MDs involve both structural and
functional modifications of the acto-myosin interactions. The
precise mechanisms are complex with probably some specifici-
ties related to each individual mutation responsible for the MD,
the severity of the translational and post-translational alterations
in myofibrillar proteins, and on the ability of skeletal muscle to
adapt to these changes. Whereas the functional consequences of
translational changes in contractile proteins have been extensively
studied, the impact of post-translational changes on the func-
tion of various contractile proteins still remains to be precisely
assessed in the context of MDs. This is a particularly exciting
time to study this question as recent findings strongly suggest that
the loss of transient structural modifications of the contractile
proteins such as reversible oxidation of specific protein residues
impair the ability of CBs to adapt very rapidly to changes in work-
load and energy supply. Future works will assess the impact of
non-permanent structural modifications of actin, myosin, and
regulatory proteins on muscle performance and determine their
potential contribution to muscle weakness in MDs.
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